Adish Patil
COO and CFO
Notable Quotes
After several quarters of pricing pressure, we believe the business has reached an inflection point supported by stabilizing realization and improving volume momentum.
The main growth driver for the volumes would be the new products both salicylic acid and the cycles the methylamines.
We will still maintain the stance that the prices have stabilized from September onwards. Just product specific variations are there little bit but more or less the prices have already stabilized.